"Rank","NCT Number","Title","Acronym","Status","Study Results","Conditions","Interventions","Outcome Measures","Sponsor/Collaborators","Gender","Age","Phases","Enrollment","Funded Bys","Study Type","Study Designs","Other IDs","Start Date","Primary Completion Date","Completion Date","First Posted","Results First Posted","Last Update Posted","Locations","Study Documents","URL"
1,"NCT02068820","Detection of SLN in Patients With Endometrial Cancer Undergoing Robotic Assisted Staging: Comparison of ISB and ICG",,"Completed","Has Results","Endometrial Cancer","Device: ISB dye and standard white light imaging|Device: ICG dye and FireFly fluorescence imaging","Number of Pelvic Sentinel Lymph Nodes (SLN) in Endometrial Cancer Patients Detected by Either ICG and/or ISB Dyes.|Negative Predictive Value (NPV) of Pelvic SLN in Endometrial Cancer in Relation to the Number of Nodes With Metastasis.","AdventHealth","Female","18 Years to 85 Years Â  (Adult, Older Adult)","Not Applicable","200","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","SLN Mapping","September 2012","January 2015","January 2015","February 21, 2014","September 10, 2019","September 10, 2019","Florida Hospital Gynecologic Oncology, Orlando, Florida, United States",,"https://ClinicalTrials.gov/show/NCT02068820"
